| LDR | 01132nam a22003131i 4500 | ||
| 001 | 000266509 | ||
| 003 | MiAaHDL | ||
| 005 | 20210817000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 008 | 880718s1980 ne a b 00100 eng | ||
| 010 | ⊔ | ⊔ | ‡a80029463 |
| 020 | ⊔ | ⊔ | ‡a0444802339 |
| 035 | ⊔ | ⊔ | ‡a(MiU)990002665090106381 |
| 035 | ⊔ | ⊔ | ‡asdr-miu.990002665090106381 |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)7178791 |
| 035 | ⊔ | ⊔ | ‡a(CaOTULAS)160494972 |
| 035 | ⊔ | ⊔ | ‡a(RLIN)MIUG82-B19074 |
| 035 | ⊔ | ⊔ | ‡z(MiU)Aleph000266509 |
| 040 | ⊔ | ⊔ | ‡dMiU |
| 050 | 0 | ⊔ | ‡aRM345 ‡b.C36 |
| 060 | ⊔ | ⊔ | ‡aQV150 C266 |
| 082 | 0 | ⊔ | ‡a616.1/061 ‡219 |
| 245 | 0 | 0 | ‡aCardiovascular and respiratory disease therapy / ‡cedited by J. C. Petrie. |
| 260 | ⊔ | ⊔ | ‡aAmsterdam ; ‡aNew York : ‡bElsevier/North-Holland Biomedical Press ; ‡aNew York : ‡bsole distributors for the U.S.A. and Canada, Elsevier/North-Holland, ‡c1980. |
| 300 | ⊔ | ⊔ | ‡aix, 243 p. : ‡bill. ; ‡c25 cm. |
| 490 | 0 | ⊔ | ‡aClinically important adverse drug interactions ; ‡vv. 1 |
| 504 | ⊔ | ⊔ | ‡aIncludes bibliographies and index. |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 650 | ⊔ | 0 | ‡aDrug interactions |
| 650 | ⊔ | 0 | ‡aRespiratory agents |
| 650 | ⊔ | 0 | ‡aCardiovascular agents |
| 700 | 1 | ⊔ | ‡aPetrie, J. C. ‡q(James C.) |
| CID | ⊔ | ⊔ | ‡a000266509 |
| DAT | 0 | ⊔ | ‡a19880718000000.0 ‡b20210817000000.0 |
| DAT | 1 | ⊔ | ‡a20210922140741.0 ‡b2023-06-24T17:33:31Z |
| CAT | ⊔ | ⊔ | ‡aSDR-MIU ‡dALMA ‡lprepare.pl-004-008 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-miu.990002665090106381 ‡aMiU ‡bSDR ‡cMIU ‡pmdp.39015003225532 ‡sMIU ‡1990002665090106381 |
| 974 | ⊔ | ⊔ | ‡bMIU ‡cMIU ‡d20230624 ‡sgoogle ‡umdp.39015003225532 ‡y1980 ‡ric ‡qbib ‡tnon-US bib date1 >= 1929 |